Skip to main content
Log in

Dutch pertussis costs remain high

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. de Greeff SC, Lugnér AK, van den Heuvel DM, Mooi FR.Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. Vaccine 27: 1932-1937, No. 13, 18 Mar 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dutch pertussis costs remain high. Pharmacoecon. Outcomes News 574, 5 (2009). https://doi.org/10.2165/00151234-200905740-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905740-00012

Keywords

Navigation